{"id":"NCT01560637","sponsor":"United Therapeutics","briefTitle":"An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension","officialTitle":"Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-11","primaryCompletion":"2021-08-12","completion":"2021-08-12","firstPosted":"2012-03-22","resultsPosted":"2022-06-02","lastUpdate":"2022-06-02"},"enrollment":471,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Arterial Hypertension"],"interventions":[{"type":"DRUG","name":"UT-15C (treprostinil diolamine)","otherNames":[]}],"arms":[{"label":"UT-15C","type":"EXPERIMENTAL"}],"summary":"This study is an international, multi-center, open-label study designed to provide oral treprostinil (UT-15C) to eligible subjects with pulmonary arterial hypertension who have completed the TDE-PH-310 study. The purpose of this study is to assess the long-term safety of UT-15C and to assess the effects of long-term treatment with UT-15C on exercise capacity.","primaryOutcome":{"measure":"Number of Adverse Events","timeFrame":"Participants will be followed every 12 weeks, at minimum, until they discontinue the study or the study is discontinued by the sponsor or for a period up to 2.5 years","effectByArm":[{"arm":"UT-15C","deltaMin":450,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":153,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","China","Denmark","France","Germany","Greece","India","Israel","Italy","Mexico","Netherlands","Poland","Singapore","South Korea","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["38055186"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":206,"n":470},"commonTop":["Headache","Diarrhoea","Flushing","Nausea","Vomiting"]}}